These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22947003)

  • 1. Conference scene: Immune signatures in the tumor and beyond.
    Kandalaft LE; Kalos M; Melief CJ; Speiser DE; Coukos G
    Immunotherapy; 2012 Aug; 4(8):761-72. PubMed ID: 22947003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer.
    Balwit JM; Kalinski P; Sondak VK; Coulie PG; Jaffee EM; Gajewski TF; Marincola FM
    J Transl Med; 2011 May; 9():60. PubMed ID: 21569425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer.
    Zloza A; Karolina Palucka A; Coussens LM; Gotwals PJ; Headley MB; Jaffee EM; Lund AW; Sharpe AH; Sznol M; Wainwright DA; Wong KK; Bosenberg MW
    J Immunother Cancer; 2017 Sep; 5(1):77. PubMed ID: 28923102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating Science into Survival: Report on the Second International Cancer Immunotherapy Conference.
    Brodsky AN; Hubbard-Lucey VM
    Cancer Immunol Res; 2016 Dec; 4(12):996-1000. PubMed ID: 27908930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating Science into Survival: Report on the Fifth International Cancer Immunotherapy Conference.
    Diken M; Kepp O; Brodsky AN
    Cancer Immunol Res; 2020 Jan; 8(1):3-6. PubMed ID: 31909729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cancer Research Institute 2013 Annual Symposium: Dynamics of host-tumor interaction.
    Tontonoz M; Gee CE
    Cancer Immunol Res; 2014 Feb; 2(2):105-11. PubMed ID: 24778274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program.
    Balwit JM; Hwu P; Urba WJ; Marincola FM
    J Transl Med; 2011 Jan; 9():18. PubMed ID: 21281484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conference overview: Cancer Immunotherapy and Immunomonitoring (CITIM): moving forward.
    Malyguine A; Umansky V; Kotlan B; Aptsiauri N; Shurin MR
    J Immunotoxicol; 2012; 9(3):231-5. PubMed ID: 22639903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1st International Conference on Human &Translational Immunology.
    Hope JL; Pulendran B; Schoenberger SP; Katsikis PD
    Nat Immunol; 2016 Dec; 18(1):1-4. PubMed ID: 27984565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy and immunomonitoring (CITIM): redefining cancer therapy.
    Malyguine A; Umansky V; Shurin MR
    J Immunotoxicol; 2009 Dec; 6(4):205-8. PubMed ID: 19908938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010.
    Lesinski GB; Carson WE; Repasky EA; Wei WZ; Kalinski P; Lotze MT; June CH; Petros W; Muthusamy N; Olencki T
    J Immunother; 2010 Sep; 33(7):659-62. PubMed ID: 20664361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.
    Butterfield LH; Disis ML; Khleif SN; Balwit JM; Marincola FM
    J Transl Med; 2010 Dec; 8():130. PubMed ID: 21138581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
    Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
    Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016.
    Gulley JL; Repasky EA; Wood LS; Butterfield LH
    J Immunother Cancer; 2017 Jul; 5(1):55. PubMed ID: 28716068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer, obesity and immunometabolism - Connecting the dots.
    Dyck L; Lynch L
    Cancer Lett; 2018 Mar; 417():11-20. PubMed ID: 29253522
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor immunology: multidisciplinary science driving basic and clinical advances.
    Keenan BP; Jaffee EM; Armstrong TD
    Cancer Immunol Res; 2013 Jul; 1(1):16-23. PubMed ID: 24409447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Tumor immunology meets oncology (TIMO) XV", April 25th-27th 2019, Halle/Saale, Germany.
    Steven A; Massa C; Seliger B
    Cancer Immunol Immunother; 2020 May; 69(5):901-909. PubMed ID: 32025850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating Science into Survival: Report on the Third International Cancer Immunotherapy Conference.
    Diken M; Chu KK; Brodsky AN
    Cancer Immunol Res; 2018 Jan; 6(1):10-13. PubMed ID: 29298782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conference Scene: Immunotherapy reaches new milestones in cancer eradication.
    Kotlan B; Umansky V; Malyguine AM; Marincola FM; Shurin MR
    Immunotherapy; 2011 Oct; 3(10):1131-7. PubMed ID: 21995567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOCIS goes south: advances in translational and clinical immunology.
    Kalergis AM; Anegon I; González PA
    Immunotherapy; 2017 Sep; 9(10):789-792. PubMed ID: 28877630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.